Clinical Trial Update: Dehydroepiandrosterone Administration in Women With Systemic Lupus Erythematosus or Primary Sjögren's Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated dehydroepiandrosterone (DHEA) administration in women with systemic lupus erythematosus or primary Sjögren's syndrome; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjögren Syndrome
• Systemic Lupus Erythematosus

Drugs mentioned

• Dehydroepiandrosterone (dehydroepiandrosterone)

Snippet

Sponsor: UMC Utrecht | Conditions: Lupus Erythematosus, Systemic, Sjogren's Syndrome | Phase 2 | Status: COMPLETED